Ray Co., Ltd. (228670.KQ)

KRW 6250.0

(-2.5%)

Total Liabilities Summary of Ray Co., Ltd.

  • Ray Co., Ltd.'s latest annual total liabilities in 2023 was 128.35 Billion KRW , up 21.22% from previous year.
  • Ray Co., Ltd.'s latest quarterly total liabilities in 2024 Q2 was 133.17 Billion KRW , down -8.23% from previous quarter.
  • Ray Co., Ltd. reported annual total liabilities of 105.88 Billion KRW in 2022, up 43.29% from previous year.
  • Ray Co., Ltd. reported annual total liabilities of 73.89 Billion KRW in 2021, up 183.87% from previous year.
  • Ray Co., Ltd. reported quarterly total liabilities of 145.1 Billion KRW for 2024 Q1, up 13.05% from previous quarter.
  • Ray Co., Ltd. reported quarterly total liabilities of 112.39 Billion KRW for 2023 Q3, up 9.9% from previous quarter.

Annual Total Liabilities Chart of Ray Co., Ltd. (2023 - 2017)

Historical Annual Total Liabilities of Ray Co., Ltd. (2023 - 2017)

Year Total Liabilities Total Liabilities Growth
2023 128.35 Billion KRW 21.22%
2022 105.88 Billion KRW 43.29%
2021 73.89 Billion KRW 183.87%
2020 26.03 Billion KRW 29.06%
2019 20.17 Billion KRW 34.42%
2018 15 Billion KRW 34.94%
2017 11.12 Billion KRW 0.0%

Peer Total Liabilities Comparison of Ray Co., Ltd.

Name Total Liabilities Total Liabilities Difference
Osang Healthcare Co.,Ltd 27.25 Billion KRW -370.927%
InBody Co.,Ltd 24.62 Billion KRW -421.322%
Curexo Inc. 6.94 Billion KRW -1749.231%
Seegene, Inc. 221.05 Billion KRW 41.934%
i-SENS, Inc. 195.32 Billion KRW 34.285%
Gencurix Inc. 21.49 Billion KRW -497.044%
Sugentech Inc. 20.73 Billion KRW -519.116%
L&C Bio Co., Ltd 105.37 Billion KRW -21.809%